Market Overview:
The global extracorporeal blood treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of chronic and lifestyle diseases, rising geriatric population, and technological advancements in the field of blood treatment. Based on type, the hemodialysis segment accounted for the largest share of the global extracorporeal blood treatment market in 2017. This segment is expected to grow at a CAGR of 5.9% from 2018 to 2030 due to increasing prevalence of renal failure across the globe. The acute dialysis segment is projected to grow at a higher CAGR than other segments during the forecast period owing to its growing demand for rapid detoxification and hemodynamic stabilization in critically ill patients. Based on application, severe sepsis was estimated as one of most lucrative applications with highest CAGR during forecast period owing high unmet needs among patients suffering from sepsis syndrome around world .
Product Definition:
Extracorporeal blood treatment is a medical procedure in which a patient's blood is circulated outside of their body. This treatment can be used to remove toxins from the blood, or to improve the function of the heart or other organs. The importance of extracorporeal blood treatment lies in its ability to improve the health of patients with serious illnesses or injuries.
Hemodialysis:
Hemodialysis is a procedure that removes waste products from the blood and purifies the blood by using dialyzers. Hemodialysis is used in patients suffering from kidney failure or diseases such as chronic renal failure, end-stage renal disease, acute kidney injury, and post transplant complications.
Acute dialysis:
Acute dialysis is a procedure where a machine removes blood from the patient through an artificial membrane and places it in another liquid that replaces the removed blood volume. The process is done outside of the body, hence it is called extracorporeal dialysis. It's major applications are for treating kidney failure or renal failure and to remove toxins from the body (urine).
Application Insights:
The severe sepsis segment dominated the global market in 2017 owing to the increasing incidence of sepsis and other infections. According to estimates reported in NCBI, around 250,000 people die of severe Sepsis every year globally. The treatment of such patients requires a combination of dialysis and blood transfusion which is not available at home as a sole source due to geographical restrictions. Hence, ECBTs are used for treating these patients thereby providing an effective alternative solution for this common problem faced by healthcare providers across the world.
The acute lung injury segment is expected to grow at lucrative growth rate over the forecast period owing to rising prevalence rates of respiratory diseases coupled with limited treatment options available for them thus creating a high demand for ECBT worldwide. Acute lung injury (ALI) occurs when there is damage or impairment in function of lungs due largely but not exclusively non-respiratory organs failure (ie., kidneys & liver).
Regional Analysis:
Europe dominated the global market in 2017 owing to the presence of a large number of players and well-established healthcare infrastructure. In addition, increasing incidence of kidney diseases is also expected to drive regional growth over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to rising incidences of chronic kidney disease coupled with improving healthcare facilities in emerging countries such as India and China. Moreover, growing medical tourism industry will also contribute towards regional demand for extracorporeal blood treatment procedures during the forecast period.
The key reasons attributed for this significant rise are an increase in cases of sepsis and multiple organ failure resulting from it along with an increase in cardiovascular diseases & trauma cases leading to increased mortality rate & morbidity rate respectively in developed nations such as U.S., U K., Germany, France etc.; which ultimately resulted into a rise in demand for ECBT procedures across these regions over last few years (previous decade).
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Chronic diseases are those that are long-term and often require ongoing treatment. Some common examples include heart disease, stroke, cancer, diabetes, and arthritis. The number of people suffering from these conditions is on the rise, which is driving the demand for extracorporeal blood treatment therapies.
- Growing awareness about available treatments: There has been a growing awareness among patients about the availability of various treatments for chronic diseases in recent years. This has led to an increase in demand for therapies such as extracorporeal blood treatment which can help improve patient outcomes significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Extracorporeal Blood Treatment Market Research Report
By Type
Hemodialysis, Acute dialysis, Apheresis
By Application
Severe Sepsis, Acute Lung Injury, Liver Failure, Cardiogenic Shock
By Companies
Fresenius Medical Care, DaVita Kidney Care, Renal Care, Dialysis Clinic, American Renal Associates, Satellite Healthcare, Atlantic Dialysis Management, Northwest Kidney Centers, Centers for Dialyssis Care, Rogosin Institute, B. Braun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Extracorporeal Blood Treatment Market Report Segments:
The global Extracorporeal Blood Treatment market is segmented on the basis of:
Types
Hemodialysis, Acute dialysis, Apheresis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Severe Sepsis, Acute Lung Injury, Liver Failure, Cardiogenic Shock
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Medical Care
- DaVita Kidney Care
- Renal Care
- Dialysis Clinic
- American Renal Associates
- Satellite Healthcare
- Atlantic Dialysis Management
- Northwest Kidney Centers
- Centers for Dialyssis Care
- Rogosin Institute
- B. Braun
Highlights of The Extracorporeal Blood Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hemodialysis
- Acute dialysis
- Apheresis
- By Application:
- Severe Sepsis
- Acute Lung Injury
- Liver Failure
- Cardiogenic Shock
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Extracorporeal Blood Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Extracorporeal blood treatment (EBT) is a medical procedure that uses a machine to remove blood from a patient. The machine separates the red blood cells from the other elements in the blood, such as plasma and platelets. This process allows doctors to treat patients with bleeding disorders or other conditions that affect their ability to clot properly.
Some of the major companies in the extracorporeal blood treatment market are Fresenius Medical Care, DaVita Kidney Care, Renal Care, Dialysis Clinic, American Renal Associates, Satellite Healthcare, Atlantic Dialysis Management, Northwest Kidney Centers, Centers for Dialyssis Care, Rogosin Institute, B. Braun.
The extracorporeal blood treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Extracorporeal Blood Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Extracorporeal Blood Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Extracorporeal Blood Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Extracorporeal Blood Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Extracorporeal Blood Treatment Market Size & Forecast, 2018-2028
4.5.1 Extracorporeal Blood Treatment Market Size and Y-o-Y Growth
4.5.2 Extracorporeal Blood Treatment Market Absolute $ Opportunity
Chapter 5 Global Extracorporeal Blood Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Extracorporeal Blood Treatment Market Size Forecast by Type
5.2.1 Hemodialysis
5.2.2 Acute dialysis
5.2.3 Apheresis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Extracorporeal Blood Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Extracorporeal Blood Treatment Market Size Forecast by Applications
6.2.1 Severe Sepsis
6.2.2 Acute Lung Injury
6.2.3 Liver Failure
6.2.4 Cardiogenic Shock
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Extracorporeal Blood Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Extracorporeal Blood Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Extracorporeal Blood Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Extracorporeal Blood Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Extracorporeal Blood Treatment Market Size Forecast by Type
9.6.1 Hemodialysis
9.6.2 Acute dialysis
9.6.3 Apheresis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Extracorporeal Blood Treatment Market Size Forecast by Applications
9.10.1 Severe Sepsis
9.10.2 Acute Lung Injury
9.10.3 Liver Failure
9.10.4 Cardiogenic Shock
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Extracorporeal Blood Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Extracorporeal Blood Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Extracorporeal Blood Treatment Market Size Forecast by Type
10.6.1 Hemodialysis
10.6.2 Acute dialysis
10.6.3 Apheresis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Extracorporeal Blood Treatment Market Size Forecast by Applications
10.10.1 Severe Sepsis
10.10.2 Acute Lung Injury
10.10.3 Liver Failure
10.10.4 Cardiogenic Shock
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Extracorporeal Blood Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Extracorporeal Blood Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Extracorporeal Blood Treatment Market Size Forecast by Type
11.6.1 Hemodialysis
11.6.2 Acute dialysis
11.6.3 Apheresis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Extracorporeal Blood Treatment Market Size Forecast by Applications
11.10.1 Severe Sepsis
11.10.2 Acute Lung Injury
11.10.3 Liver Failure
11.10.4 Cardiogenic Shock
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Extracorporeal Blood Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Extracorporeal Blood Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Extracorporeal Blood Treatment Market Size Forecast by Type
12.6.1 Hemodialysis
12.6.2 Acute dialysis
12.6.3 Apheresis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Extracorporeal Blood Treatment Market Size Forecast by Applications
12.10.1 Severe Sepsis
12.10.2 Acute Lung Injury
12.10.3 Liver Failure
12.10.4 Cardiogenic Shock
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Extracorporeal Blood Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Extracorporeal Blood Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Extracorporeal Blood Treatment Market Size Forecast by Type
13.6.1 Hemodialysis
13.6.2 Acute dialysis
13.6.3 Apheresis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Extracorporeal Blood Treatment Market Size Forecast by Applications
13.10.1 Severe Sepsis
13.10.2 Acute Lung Injury
13.10.3 Liver Failure
13.10.4 Cardiogenic Shock
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Extracorporeal Blood Treatment Market: Competitive Dashboard
14.2 Global Extracorporeal Blood Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Medical Care
14.3.2 DaVita Kidney Care
14.3.3 Renal Care
14.3.4 Dialysis Clinic
14.3.5 American Renal Associates
14.3.6 Satellite Healthcare
14.3.7 Atlantic Dialysis Management
14.3.8 Northwest Kidney Centers
14.3.9 Centers for Dialyssis Care
14.3.10 Rogosin Institute
14.3.11 B. Braun
